Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
CC transcript
Inv. presentation
Quarterly results
Director departure
Emergent BioSolutions Inc. (EBS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13G/A STATE STREET CORP reports a 2.2% stake in EXIT FILING EMERGENT BIOSOLUTIONS INC
10/10/2023 SC 13G/A VANGUARD GROUP INC reports a 5.1% stake in Emergent BioSolutions Inc.
10/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
10/02/2023 8-K Quarterly results
08/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Emergent’s Statement Regarding the Passing of a Director of the Board"
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "LUTIONS REPORTS FINANCIAL RESULTS FOR SECOND QUARTER",
"PROPRIETARY AND CONFIDENTIAL 2Q2 2023"
08/08/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position"
07/31/2023 8-K Quarterly results
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVE TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT. 11."
07/21/2023 8-K Quarterly results
06/05/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/31/2023 8-K Investor presentation
Docs: "Emergent BioSolutions Inc. 2023 Annual Meeting of Stockholders May 25, 2023 Agenda 22023 Virtual Annual Meeting of Stockholders INTRODUCTION 1. Call to"
05/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/15/2023 8-K Asset disposition
Docs: "Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic GAITHERSBURG, Md., May 15, 2023",
"Unaudited Pro Forma Condensed Consolidated Financial Information"
05/09/2023 8-K Quarterly results
Docs: "LUTIONS REPORTS FINANCIAL RESULTS FOR FIRST QUARTER",
"PROPRIETARY AND CONFIDENTIAL 2Q1 2023"
04/24/2023 DEFR14A Form DEFR14A - Revised definitive proxy soliciting materials:
04/17/2023 8-K Quarterly results
04/14/2023 ARS Form ARS - Annual Report to Security Holders:
04/14/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/14/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/29/2023 8-K Quarterly results
03/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "COMPANY CONFIDENTIAL SCHEDULE 1 VESTING CRITERIA FOR"
02/27/2023 8-K Quarterly results
Docs: "LUTIONS REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER",
"PROPRIETARY AND CONFIDENTIAL 2Q4FY 2022"
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 10.8% stake in Emergent BioSolutions Inc.
01/20/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/10/2023 SC 13G/A STATE STREET CORP reports a 11.7% stake in AMENDED FILING EMERGENT BIOSOLUTIONS INC
01/09/2023 8-K Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities, Departure of Directors or Ce...
Docs: "of Sharpened Strategic Focus Announces Preliminary 2022 Financial Results GAITHERSBURG, Md., January 9, 2023"
01/05/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "to U.S. Department of Defense GAITHERSBURG, Md., Jan. 5, 2023"
12/06/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
09/26/2022 8-K Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits &n...
Docs: "Investor Contact Robert Burrows Vice President, Investor Relations"
08/12/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy